Besides its host-beneficial role in hematopoiesis and protection from infection, dysregulated production of G-CSF has been linked to autoinflammatory disorders such as psoriasis and inflammatory arthritis [41–43] and targeting G-CSF has been proposed as a therapeutic approach against these diseases [44]. The gene discussed is CSF3; the disease is psoriasis.